MedTrace Logo

ESPB vs iPACK+ACB in Total Knee Arthroplasty

NCT06302218 · Status: NOT_YET_RECRUITING · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 60

Last updated 2024-03-08

No results posted yet for this study

Summary

Effect of iPACK block with Adductor Canal Block and ESPB on pain management, and NLR and PLR following knee arthroplasty

Conditions

  • Knee Arthritis
  • Knee Arthropathy
  • Knee Osteoarthritis
  • Knee Pain Chronic
  • Knee Disease
  • Knee Rheumatism

Interventions

DRUG

Ropivacaine 0.2% Injectable Solution

iPACK block + Adductor Canal Block

DRUG

Ropivacaine 0.2% Injectable Solution

Erector Spinae Plane Block

DRUG

control group

only spinal anesthesia

Sponsors & Collaborators

  • Poznan University of Medical Sciences

    lead OTHER

Principal Investigators

  • Łukasz Łapaj, Ph.D. · Poznań University of Medical Sciences

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
TRIPLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
100 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2024-04-01
Primary Completion
2024-09-30
Completion
2025-10-30

Countries

  • Poland

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06302218 on ClinicalTrials.gov